https://www.news-medical.net/news/20091030/Bayer-HealthCares-Phase-II-study-results-of-imaging-agent-florbetaben.aspx
Bayer HealthCare presented results from a global Phase II study of florbetaben, its imaging agent in development for the detection of cerebral beta-Amyloid...
phase ii studybayer healthcareimaging agentresults